1. Home
  2. DENN vs AKBA Comparison

DENN vs AKBA Comparison

Compare DENN & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DENN
  • AKBA
  • Stock Information
  • Founded
  • DENN 1953
  • AKBA 2007
  • Country
  • DENN United States
  • AKBA United States
  • Employees
  • DENN N/A
  • AKBA N/A
  • Industry
  • DENN Restaurants
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DENN Consumer Discretionary
  • AKBA Health Care
  • Exchange
  • DENN Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • DENN 329.8M
  • AKBA 336.2M
  • IPO Year
  • DENN 1989
  • AKBA 2014
  • Fundamental
  • Price
  • DENN $5.93
  • AKBA $2.07
  • Analyst Decision
  • DENN Strong Buy
  • AKBA Strong Buy
  • Analyst Count
  • DENN 5
  • AKBA 1
  • Target Price
  • DENN $7.90
  • AKBA $7.50
  • AVG Volume (30 Days)
  • DENN 820.9K
  • AKBA 2.4M
  • Earning Date
  • DENN 02-12-2025
  • AKBA 03-13-2025
  • Dividend Yield
  • DENN N/A
  • AKBA N/A
  • EPS Growth
  • DENN N/A
  • AKBA N/A
  • EPS
  • DENN 0.33
  • AKBA N/A
  • Revenue
  • DENN $453,013,000.00
  • AKBA $169,879,000.00
  • Revenue This Year
  • DENN N/A
  • AKBA N/A
  • Revenue Next Year
  • DENN $4.07
  • AKBA $30.85
  • P/E Ratio
  • DENN $18.13
  • AKBA N/A
  • Revenue Growth
  • DENN N/A
  • AKBA N/A
  • 52 Week Low
  • DENN $5.37
  • AKBA $0.80
  • 52 Week High
  • DENN $11.16
  • AKBA $2.48
  • Technical
  • Relative Strength Index (RSI)
  • DENN 47.44
  • AKBA 63.74
  • Support Level
  • DENN $5.63
  • AKBA $1.72
  • Resistance Level
  • DENN $6.03
  • AKBA $2.00
  • Average True Range (ATR)
  • DENN 0.29
  • AKBA 0.09
  • MACD
  • DENN -0.01
  • AKBA 0.02
  • Stochastic Oscillator
  • DENN 42.11
  • AKBA 94.67

About DENN Denny's Corporation

Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor, is approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: